Introduction
Methods
Patients
Tumor location and staging
Propensity score matching (PSM)
Gauze pad band (GPB)
Operative Technique
Measurement of blood loss
Pathological assessment
Endpoint
Statistical analysis
Results
Postmatching baseline characteristics
Characteristics | Prematching baseline characterstics | p | Postmatching characterstics | p | ||
---|---|---|---|---|---|---|
GPB group (76) | NGPB group (157) | GPB group (63) | NGPB group (126) | |||
Male | 44 (57.9%) | 97 (61.8%) | 0.569 | 37 (58.7%) | 79 (62.7%) | 0.597 |
Age, year, mean ± SD | 63.95 ± 13.13 | 63.82 ± 12.19 | 0.940 | 63.75 ± 12.92 | 63.28 ± 12.73 | 0.814 |
BMI | 0.697 | 0.522 | ||||
> 25 kg/m2 | 28 (36.8%) | 62 (39.5%) | 21 (33.3%) | 48 (38.1%) | ||
≤ 25 kg/m2 | 48 (63.2%) | 95 (60.5%) | 42 (66.7%) | 78 (61.9%) | ||
Alb, g/L, mean ± SD | 36.53 ± 5.17 | 35.95 ± 5.24 | 0.425 | 36.65 ± 5.14 | 36.18 ± 4.89 | 0.539 |
Hb, g/L, mean ± SD | 121.27 ± 12.98 | 119.52 ± 13.26 | 0.344 | 119.53 ± 12.75 | 118.95 ± 13.13 | 0.774 |
Tumor size, cm, mean ± SD | 3.48 ± 1.73 | 3.64 ± 1.57 | 0.496 | 3.65 ± 1.64 | 3.47 ± 1.68 | 0.494 |
Height of distal edge of the tumor, cm, mean ± SD | 0.034 | 0.615 | ||||
4.21 ± 2.16 | 4.85 ± 2.14 | 4.26 ± 2.26 | 4.44 ± 2.20 | |||
Tumor location | 0.036 | 0.664 | ||||
Low rectum (< 5 cm) | 53 (69.7%) | 87 (55.4%) | 43 (68.3%) | 82 (65.1%) | ||
Middle rectum (5.1–10 cm) | 23 (30.3%) | 70 (44.6%) | 20 (31.7%) | 44 (34.9%) | ||
ASA score | 0.890 | 0.741 | ||||
I | 15 (19.7%) | 34 (21.7%) | 11 (17.5%) | 28 (22.2%) | ||
II | 48 (63.2%) | 94 (59.9%) | 42 (66.7%) | 80 (63.5%) | ||
III | 13 (17.1%) | 29 (18.4%) | 10 (15.8%) | 18 (14.3%) | ||
Preoperative serum CEA, ng/ml, mean ± SD | 0.734 | 0.792 | ||||
6.60 ± 3.17 | 6.44 ± 3.27 | 6.64 ± 3.28 | 6.77 ± 3.16 | |||
Clinical stage | 0.916 | 0.646 | ||||
I | 17 (22.4%) | 32 (20.4%) | 14 (22.2%) | 21 (16.7%) | ||
II | 23 (30.3%) | 51 (32.5%) | 22 (34.9%) | 46 (36.5%) | ||
III | 36 (47.3%) | 74 (47.1%) | 27 (42.9%) | 59 (46.8%) | ||
Degree of histological differentiation | 0.715 | 0.847 | ||||
Well | 11 (14.5%) | 17 (10.8%) | 7 (11.1%) | 12 (9.5%) | ||
Moderate | 49 (64.5%) | 107 (68.2%) | 44 (69.8%) | 93 (73.8%) | ||
Poor + undifferentiated | 16 (21.0%) | 33 (21.0%) | 12 (19.1%) | 21 (16.7%) | ||
Neoadjuvant chemoradiation | 54 (71.1%) | 85 (54.1%) | 0.014 | 39 (61.9%) | 71 (56.3%) | 0.465 |
Assistant's experience | 0.792 | 0.645 | ||||
> 5 years after resident training | 21 (27.6%) | 46 (29.3%) | 16 (25.4%) | 36 (28.6%) | ||
≤ 5 years after resident training | 55 (72.4%) | 111 (70.7%) | 47 (74.6%) | 90 (71.4%) |
Intraoperative and postoperative characteristics
Characteristics | GPB group (63) | NGPB group (126) | p |
---|---|---|---|
Operative time, min, median (range) | 203 (192, 218) | 233 (223, 247) | < 0.001 |
Blood loss, ml, median (range) | 48 (36, 56) | 67 (58, 76) | < 0.001 |
Anastomotic height, cm, mean ± SD | 3.17 ± 1.55 | 3.14 ± 1.47 | 0.886 |
Protective ileostomy | 35 (55.6%) | 71 (56.3%) | 0.917 |
Splenic flexure mobilization | 26 (41.3%) | 48 (38.1%) | 0.673 |
Conversion to open surgery | 11 (17.5%) | 26 (20.6%) | 0.604 |
Patients with one cartridge transection | 36/63 (57.1%) | 51/126 (40.5%) | 0.030 |
Male with one cartridge | 23/37 (62.2%) | 29/79 (36.7%) | 0.010 |
Female with one cartridge | 13/26 (50.0%) | 22/47 (46.8%) | 0.794 |
Low rectal cancer with one cartridge | 19/43 (44.2%) | 20/82 (24.4%) | 0.023 |
Middle rectal cancer with one cartridge | 17/20 (85.0%) | 31/44 (70.5%) | 0.213 |
BMI > 25 kg/m2 with one cartridge | 14/21 (66.7%) | 19/48 (39.6%) | 0.038 |
BMI ≤ 25 kg/m2 with one cartridge | 22/42 (52.4%) | 32/78 (41.0%) | 0.233 |
Tumor > 5 cm with one cartridge | 8/9 (88.9%) | 9/23 (39.1%) | 0.032 |
Patients with more than two cartridges transection | |||
0 | 0 | – | |
No. of cartridges,median (range) | 1 (1, 2) | 2 (1, 2) | 0.031 |
Postoperative Complications (< 30 days) | 11 (17.5%) | 23 (18.3%) | 0.893 |
Clavien–Dindo grade | 0.974 | ||
I | 4 (6.3%) | 9 (7.1%) | |
II | 3 (4.8%) | 6 (4.8%) | |
IIIa | 3 (4.8%) | 4 (3.2%) | |
IIIb | 1 (1.6%) | 4 (3.2%) | |
Types of complications | |||
Anatomostic leakage | 2 (3.2%) | 4 (3.2%) | 1.000 |
Anastomotic bleeding | 1 (1.6%) | 2 (1.6%) | 1.000 |
Hemorrhage | 1 (1.6%) | 3 (2.4%) | 1.000 |
Surgery site infections | 4 (6.3%) | 6 (4.8%) | 0.909 |
Urinary retention | 3 (4.8%) | 7 (5.6%) | 1.000 |
Thrombosis, thrombus, or embolism | 0 | 1 (0.8%) | 1.000 |
Pathological characteristics
Characteristics | GPB group (63) | NGPB group (126) | p |
---|---|---|---|
No. with circumferential margin positivity | 1 (1.6%) | 4 (3.2%) | 0.873 |
No. with negative margin (≥ 1 mm) | 61 (96.8%) | 119 (94.4%) | 0.717 |
R0 ressection rate | 60 (95.2%) | 115 (91.3%) | 0.492 |
Distal ressection margin,cm,mean ± SD | 2.74 ± 0.76 | 2.16 + 0.68 | < 0.001 |
Low rectum (< 5 cm) | 1.78 ± 0.67 | 1.23 ± 0.59 | < 0.001 |
Middle rectum (5.1–10 cm) | 3.03 ± 0.83 | 2.97 ± 0.77 | 0.641 |
Total mesorectal excision | 0.022 | ||
Complete | 55 (87.3%) | 88 (69.8%) | |
Nearly complete | 6 (9.5%) | 21 (16.7%) | |
Incomplete | 2 (3.2%) | 17 (13.5%) | |
Degree of histological differentiation | 0.931 | ||
Well | 6 (9.5%) | 10 (7.9%) | |
Moderate | 46 (73.0%) | 93 (73.8%) | |
Poor + Undifferentiated | 11 (17.5%) | 23 (18.3%) | |
Pathological tumor stage | 0.730 | ||
pT1 | 6 (9.5%) | 8 (6.3%) | |
pT2 | 12 (19.0%) | 24 (19.0%) | |
pT3 | 45 (71.5%) | 94 (74.7%) | |
Pathological nodal status | 0.019 | ||
pN0 | 30 (47.6%) | 75 (59.5%) | |
pN1 | 19 (30.2%) | 41 (32.5%) | |
pN2 | 14 (22.2%) | 10 (8.0%) | |
Stage | 0.294 | ||
I | 11 (17.5%) | 26 (20.6%) | |
II | 19 (30.2%) | 49 (38.9%) | |
III | 33 (52.3%) | 51 (40.5%) | |
Tumor size, cm, mean ± SD | 3.65 ± 1.64 | 3.47 ± 1.68 | 0.494 |
No. with lymphovascular invasion | 1 (1.6%) | 2 (1.6%) | 1.000 |
Total length of cartridges, cm, mean ± SD | 6.88 ± 1.27 | 7.28 ± 1.25 | 0.040 |
No. of lymph nodes examined, median (range) | 19 (17,22) | 17 (14,20) | < 0.001 |
No. of positive lymph nodes, median (range) | 1 (0,3) | 0 (0,2) | 0.046 |